Autonomic Sleep

Sleep disturbance alone explains approximately 50% of the quality-of-life reduction in people with postural orthostatic tachycardia syndrome (POTS). The mechanism: POTS involves excessive norepinephrine accumulation and sympathetic overactivity that persists at night, preventing the parasympathetic activation sleep requires. Standard sleep advice — consistent bedtime, dark room, no screens — does not address this autonomic imbalance,

Nighttime heart racing after COVID is typically an autonomic problem, not a cardiac one. The vagus nerve normally suppresses heart rate during sleep through parasympathetic activation. When COVID damages vagal function, parasympathetic activity at night is insufficient — leaving the sympathetic nervous system unopposed. Heart rate stays elevated, catecholamine surges produce adrenaline-like wakeups, and sleep

SARS-CoV-2 can infect and inflame the vagus nerve — the nerve that controls the parasympathetic activation your body needs to enter and maintain sleep. Postmortem studies have detected viral RNA inside vagal tissue accompanied by inflammatory cell infiltration. A pilot study found vagus nerve thickening that trended toward statistical significance in post-COVID adults using ultrasound

Nootropics can disrupt sleep through three neurotransmitter pathways: cholinergic (alpha-GPC, lion’s mane, huperzine A raise acetylcholine and intensify REM), dopaminergic (modafinil, L-tyrosine extend wakefulness), and glutamatergic (racetams increase excitatory activity). The approach: classify each supplement by its disruption pathway, restrict centrally active compounds to before midday, and if needed, add evening counterbalancing agents — L-theanine,

Choline bitartrate and phosphatidylcholine have the lowest risk of sleep disruption because they do not cross the blood-brain barrier efficiently. Alpha-GPC has the highest risk — it crosses the blood-brain barrier efficiently and may raise central acetylcholine levels. CDP-choline (citicoline) produces unpredictable effects: some users report insomnia, others report drowsiness, likely because it modulates dopamine

Supplements that raise acetylcholine — including alpha-GPC, galantamine, huperzine A, lion’s mane, and CDP-choline — intensify dreams because acetylcholine is the neurotransmitter that triggers and sustains REM sleep. During natural sleep, acetylcholine drops to near-zero during deep NREM and surges during REM. Cholinergic supplements alter this rhythm by keeping acetylcholine elevated during phases when it